Detection of antibacterial-like activity on a silica surface: Fluoroquinolones and their environmental metabolites

Environmental Science and Pollution Research

Volumn 19, Issue 7, 2012, Pages 2795-2801

  Lewis, Gareth ^a,b   Juhasz, Albert ^a,b   Smith, Euan ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b University of South Australia and CRC for Contamination Assessment and Remediation of the Environment   (Australia)

Author keywords

Biosolid; Ciprofloxacin; Enrofloxacin; Fluoroquinolone; Metabolite; Norfloxacin; PhACs; Pharmaceutically active compounds; Pharmaceuticals and personal care products; PPCPs; Resistance to antibiotics; Risk; Transformation product

Indexed keywords

AGRICULTURAL LAND; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOSOLID; BIOTRANSFORMATION; FERMENTATION; GROWTH RATE; METABOLITE; PHYSICOCHEMICAL PROPERTY; RESPIRATORY DISEASE; SILICA;

ANIMALIA; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM GILVUM;

EID: 84871712679     PISSN: 09441344     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11356-012-0781-8     Document Type: Article

References (32)

1. Adjei MD, Heinze TM, Deck J, Freeman JP, Williams AJ, Sutherland JB (2006) Transformation of the antibacterial agent norfloxacin by environmental mycobacteria. Appl Environ Microbiol 72(9): 5790-5793.
2. Adjei MD, Heinze TM, Deck J, Freeman JP, Williams AJ, Sutherland JB (2007) Acetylation and nitrosation of ciprofloxacin by environmental strains of mycobacteria. Can J Microbiol 53: 144-147.
3. Alder AC, McArdell CS, Golet EM, Ibric S, Molnar E, Nipales NS, Giger W (2001) Occurrence and fate of fluoroquinolones, macrolide, and sulfonamide antibiotics during wastewater treatment and in ambient waters in Switzerland. In: Daughton CG, Jones-Lepp T (eds) Pharmaceuticals and personal care products in the environment: scientific and regulatory issues. American Chemical Society, Washington DC, pp 168-190.
4. Anadón A, Martínez-Larrañaga MR, Díaz MJ, Bringas P, Martínez MA, Fernández-Cruz ML, Fernández MC, Fernández R (1995) Pharmacokinetics and residues of enrofloxacin in chickens. Am J Vet Res 56: 501-506.
5. Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M (1999) Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs. Am J Vet Res 60: 1377-1382.
6. Anadón A, Martínez-Larrañaga MR, Iturbe J, Martínez MA, Diaz MJ, Frejo MT, Martínez M (2001) Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens. Res Vet Sci 71(2): 101-109.
7. Beausse J (2004) Selected drugs in solid matrices: a review of environmental determination, occurrence and properties of principal substances. TrAC 23(10-11): 753-761.
8. Bêhal V (2006) Mode of action of microbial bioactive metabolites. Folia Microbiol 51(5): 359-369.
9. Brownlee S (2000) Antibiotics in feed. Organic Consumers Association. Viewed 26 May 2011. < http://www. organicconsumers. org/Toxic/antibioticsinfeed. cfm>.
10. Burhenne J, Ludwig M, Nikoloudis P, Spiteller M (1997) Photolytic degradation of fluoroquinolone carboxylic acids in aqueous solution. Part I: primary photoproducts and half-lives. Environ Sci Pollut Res 4(1): 10-15.
11. Cardoza LA, Knapp CW, Larive CK, Belden JB, Lydy M, Graham DW (2005) Factors affecting the fate of ciprofloxacin in aquatic field systems. Water Air Soil Pollut 161: 383-398.
12. Cester CC, Toutain PL (1997) A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog. J Pharm Sci 86: 1148-1155.
13. Chander Y, Kumar K, Goyal SM, Gupta SC (2005) Antibacterial activity of soil-bound antibiotics. J Environ Qual 34: 1952-1957.
14. Goldstein EJC (1987) Norfloxacin, a fluoroquinolone antibacterial agent: classification, mechanism of action, and in vitro activity. Am J Med 82(6): 3-17.
15. Golet EM, Strehler A, Alder AC, Giger W (2002) Determination of fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction. Anal Chem 74: 5455-5462.
16. Kumar K, Gupta SC, Chander Y, Singh AK (2005) Antibiotic use in agriculture and its impact on the terrestrial environment advances in agronomy. In: Sparks DL (ed) volume, 87th edn. Academic Press, Salt Lake City, UT, pp 1-54.
17. Kümmerer K (2003) Pharmaceuticals in the environment: sources, fate, effects and risks, 2nd edn. Springer-Verlag, Berlin.
18. Lewis G (2011) Thesis: fate and dynamics of fluoroquinolone antibiotics as pharmaceutically active compounds (PhACs) in the soil environment. Viewed 29th December 2011, < http://arrow. unisa. edu. au: 8081/1959. 8/119064>.
19. Martini N, Eloff JN (1998) The preliminary isolation of several antibacterial compounds from Combretum erythrophyllum (Combretaceae). J Ethnopharmacol 62: 255-263.
20. Nowara A, Burhenne J, Spiteller M (1997) Binding of fluoroquinolone carboxylic acid derivatives to clay minerals. J Agric Food Chem 45(4): 1459-1463.
21. Picó Y, Andreu V (2007) Fluoroquinolones in soil-risks and challenges. Anal Bioanal Chem 387: 1287-1299.
22. Rysz M, Alvarez PJJ (2004) Amplification and attenuation of tetracycline resistance in soil bacteria: aquifer column experiments. Water Res 38(17): 3705-3712.
23. Sasabe H, Tsuji A, Sugiyama Y (1998) Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. J Pharmacol Exp Ther 284(3): 1033-1039.
24. Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M (2003) Antibiotic resistance-the interplay between antibiotic use in animals and human beings. Lancet Infect Dis 3(1): 47-51.
25. Stenström TA (1989) Bacterial hydrophobicity, an overall parameter for the measurement of adhesion potential to soil particles. Appl Environ Microbiol 55(1): 142-147.
26. Thiele-Bruhn S, Beck I-C (2005) Effects of sulfonamide and tetracycline antibiotics on soil microbial activity and microbial biomass. Chemosphere 59(4): 457-465.
27. Waters B, Davies J (1997) Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics. Antimicrob Agent Chemother 41(12): 2766-2769.
28. Wetzstein H-G, Schneider J, Karl W (2006) Patterns of metabolites produced from the fluoroquinolone enrofloxacin by Basidiomycetes indigenous to agricultural sites. Appl Microbiol Biotechnol 71: 90-100.
29. Wetzstein H-G, Schneider J, Karl W (2009) Comparative biotransformation of fluoroquinolone antibiotics in matrices of agricultural relevance. In: Veterinary pharmaceuticals in the environment Henderson KL, Coats JR (eds). Chapter 6: 67-91.
30. WHO (1998) Report of a WHO Meeting Geneva, Switzerland: use of quinolones in food animals and potential impact on human health. WHO/EMC/ZDI/98. 10. Viewed 26 May 2011. < http://search. who. int/search?q=use+of+quinolone& ie=utf8& site=default_collection& client=_en& proxystylesheet=_en& output=xml_no_dtd& oe=utf8>.
31. Wise R (2002) Antimicrobial resistance: priorities for action. J Antimicrob Chemother 49: 585-586.
32. Zielezny Y, Groeneweg J, Vereecken H, Tappe W (2006) Impact of sulfadiazine and chlorotetracycline on soil bacterial community structure and respiratory activity. Soil Biol Biochem 38(8): 2372-2380.